+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunochemicals Market by Product Type (Antibodies, Antigens, Kits), Application (Clinical Research, Diagnostics, Drug Discovery), End User, Technology, Format, Label Type - Global Forecast 2025-2030- Product Image
Immunochemicals Market by Product Type (Antibodies, Antigens, Kits), Application (Clinical Research, Diagnostics, Drug Discovery), End User, Technology, Format, Label Type - Global Forecast 2025-2030- Product Image
Sale

Immunochemicals Market by Product Type (Antibodies, Antigens, Kits), Application (Clinical Research, Diagnostics, Drug Discovery), End User, Technology, Format, Label Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889477
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The immunochemicals market is evolving rapidly, driven by sustained advancements in molecular biology, automation, digitalization, and the need for robust diagnostic and research tools. This environment requires leadership that can navigate regulatory changes, operational complexities, and region-specific dynamics with decisive strategies.

Market Snapshot: Immunochemicals Market Performance and Growth Drivers

The Immunochemicals Market grew from USD 3.12 billion in 2024 to USD 3.35 billion in 2025. It is expected to continue growing at a CAGR of 7.27%, reaching USD 4.76 billion by 2030. This growth is shaped by increasing adoption in healthcare and life sciences, underpinned by product innovation, evolving end-user needs, and a shifting global regulatory landscape. The market’s foundational products—antibodies, antigens, kits, and reagents—directly support contemporary diagnostics, therapeutic development, and advanced research applications.

Scope & Segmentation of the Immunochemicals Market

  • Product Types: Antibodies (monoclonal: humanized, mouse, rabbit; polyclonal: goat, rabbit; recombinant: fusion, single chain), Antigens (haptens, peptide antigens: catalog and custom, protein antigens: purified and recombinant), Kits (ELISA: competitive, indirect, sandwich; flow cytometry, IHC: direct and indirect immunoperoxidase, Western blot: semi dry, wet transfer), Reagents (blocking agents, buffers and destainers, secondary antibodies: conjugated and unconjugated, substrates).
  • Applications: Clinical research, diagnostics, drug discovery, and basic research.
  • End Users: Academic institutes, contract research organizations, diagnostic laboratories, and pharmaceutical/biotech companies.
  • Technologies: ELISA, flow cytometry (cell surface and intracellular analysis), immunohistochemistry, Western blot.
  • Formats: Liquid and lyophilized presentations.
  • Label Types: Enzyme, fluorescent, luminescent, and radioactive.
  • Regional Coverage:
    • Americas: United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina.
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland.
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan.
  • Leading Companies: Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Becton, Dickinson and Company, Abcam plc, Bio-Techne Corporation, Promega Corporation.

Key Takeaways for Senior Decision-Makers

  • Scientific advances and automation are transforming assay development, making immunochemicals integral to next-generation diagnostics and therapies.
  • Heightened regulatory scrutiny is increasing the need for product standardization and quality control, raising operational and compliance expectations globally.
  • End-user diversity—spanning academic, clinical, and biotech stakeholders—drives demand for customized products and solutions tailored to precise research or diagnostic needs.
  • Digital transformation, including data analytics and cloud-based platforms, is streamlining workflows and strengthening collaborations across the value chain.
  • Strategic partnerships, mergers, and targeted R&D are enabling companies to expand portfolios, reduce costs, and enhance responsiveness to market shifts.
  • Adopting modular production capabilities and vertically integrated supply chains improves resilience and optimizes pricing in the face of external pressures.

Tariff Impact: Managing New Constraints and Supply Chain Realignment

  • US-imposed tariffs in 2025 have led to fundamental changes in procurement and vendor relationships for immunochemical products.
  • Some organizations are diversifying supplier bases and leveraging local contract manufacturing to reduce exposure and stabilize supply.
  • Operational and financial impact is prompting adoption of alternative product formats and more agile pricing strategies to ensure continuity in research and diagnostics.
  • Vertically integrated companies with in-house capacity are better positioned to maintain profitability and absorb supply chain disruptions caused by tariffs.

Methodology & Data Sources

Findings are based on a robust combination of primary interviews with R&D leaders, procurement managers, and end users, supplemented by secondary research from peer-reviewed journals, industry reports, and regulatory filings. Data triangulation and internal expert validation were employed to ensure accuracy, depth, and actionability.

Why This Report Matters

  • Offers actionable market intelligence to support strategic decision-making and resource planning for leaders in diagnostics, research, and manufacturing.
  • Identifies high-impact growth opportunities by mapping technology trends, regulatory shifts, and evolving end-user preferences across regions.
  • Enables competitive benchmarking and market positioning through detailed segmentation and analysis of leading industry players.

Conclusion

Leaders seeking a comprehensive understanding of the immunochemicals market will find this report essential for anticipating change, mitigating risk, and unlocking new sources of value. Forward-thinking strategies grounded in data-driven insights will position stakeholders for long-term success in this dynamic environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for recombinant monoclonal antibodies engineered for bispecific therapeutic targeting in cancer
5.2. Increasing integration of automated immunoassay platforms in high throughput clinical diagnostics
5.3. Expansion of multiplex bead-based immunoassays for comprehensive cytokine profiling in translational research
5.4. Adoption of single-cell proteomics technologies combining immunostaining with mass spectrometry in immunology studies
5.5. Development of next-generation Fc-engineered antibodies for enhanced effector function in autoimmune disorder treatments
5.6. Growth of point-of-care lateral flow immunoassays utilizing novel gold nanoparticle conjugates for infectious disease detection
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immunochemicals Market, by Product Type
8.1. Introduction
8.2. Antibodies
8.2.1. Monoclonal
8.2.1.1. Humanized
8.2.1.2. Mouse
8.2.1.3. Rabbit
8.2.2. Polyclonal
8.2.2.1. Goat
8.2.2.2. Rabbit
8.2.3. Recombinant
8.2.3.1. Fusion
8.2.3.2. Single Chain
8.3. Antigens
8.3.1. Haptens
8.3.2. Peptide Antigens
8.3.2.1. Catalog Peptide
8.3.2.2. Custom Peptide
8.3.3. Protein Antigens
8.3.3.1. Purified Protein
8.3.3.2. Recombinant Protein
8.4. Kits
8.4.1. Elisa Kits
8.4.1.1. Competitive Elisa
8.4.1.2. Indirect Elisa
8.4.1.3. Sandwich Elisa
8.4.2. Flow Cytometry Kits
8.4.3. Ihc Kits
8.4.3.1. Direct Immunoperoxidase
8.4.3.2. Indirect Immunoperoxidase
8.4.4. Western Blot Kits
8.4.4.1. Semi Dry Transfer
8.4.4.2. Wet Transfer
8.5. Reagents
8.5.1. Blocking Agents
8.5.2. Buffers And Destainers
8.5.3. Secondary Antibodies
8.5.3.1. Conjugated
8.5.3.2. Unconjugated
8.5.4. Substrates
9. Immunochemicals Market, by Application
9.1. Introduction
9.2. Clinical Research
9.3. Diagnostics
9.4. Drug Discovery
9.5. Research
10. Immunochemicals Market, by End User
10.1. Introduction
10.2. Academic Institutes
10.3. Contract Research Organizations
10.4. Diagnostic Laboratories
10.5. Pharmaceutical Biotech Companies
11. Immunochemicals Market, by Technology
11.1. Introduction
11.2. Elisa
11.3. Flow Cytometry
11.3.1. Cell Surface Analysis
11.3.2. Intracellular Analysis
11.4. Immunohistochemistry
11.5. Western Blot
12. Immunochemicals Market, by Format
12.1. Introduction
12.2. Liquid
12.3. Lyophilized
13. Immunochemicals Market, by Label Type
13.1. Introduction
13.2. Enzyme
13.3. Fluorescent
13.4. Luminescent
13.5. Radioactive
14. Americas Immunochemicals Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Immunochemicals Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Immunochemicals Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Danaher Corporation
17.3.3. Merck KGaA
17.3.4. Agilent Technologies, Inc.
17.3.5. Bio-Rad Laboratories, Inc.
17.3.6. PerkinElmer, Inc.
17.3.7. Becton, Dickinson and Company
17.3.8. Abcam plc
17.3.9. Bio-Techne Corporation
17.3.10. Promega Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. IMMUNOCHEMICALS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IMMUNOCHEMICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. IMMUNOCHEMICALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. IMMUNOCHEMICALS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. IMMUNOCHEMICALS MARKET: RESEARCHAI
FIGURE 28. IMMUNOCHEMICALS MARKET: RESEARCHSTATISTICS
FIGURE 29. IMMUNOCHEMICALS MARKET: RESEARCHCONTACTS
FIGURE 30. IMMUNOCHEMICALS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IMMUNOCHEMICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMUNOCHEMICALS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IMMUNOCHEMICALS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY HUMANIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY HUMANIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY MOUSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY MOUSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RABBIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RABBIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY GOAT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY GOAT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RABBIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RABBIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SINGLE CHAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SINGLE CHAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY HAPTENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY HAPTENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CATALOG PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CATALOG PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CUSTOM PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CUSTOM PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PURIFIED PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PURIFIED PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY DIRECT IMMUNOPEROXIDASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY DIRECT IMMUNOPEROXIDASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY INDIRECT IMMUNOPEROXIDASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY INDIRECT IMMUNOPEROXIDASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SEMI DRY TRANSFER, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SEMI DRY TRANSFER, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY WET TRANSFER, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY WET TRANSFER, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY BLOCKING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY BLOCKING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY BUFFERS AND DESTAINERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY BUFFERS AND DESTAINERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CONJUGATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CONJUGATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY UNCONJUGATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY UNCONJUGATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY SUBSTRATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CELL SURFACE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY CELL SURFACE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY INTRACELLULAR ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY INTRACELLULAR ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LYOPHILIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ENZYME, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY ENZYME, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FLUORESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY FLUORESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LUMINESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY LUMINESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RADIOACTIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY RADIOACTIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 249. CANADA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. CANADA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. CANADA IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 252. CANADA IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 253. CANADA IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2024 (USD MILLION)
TABLE 254. CANADA IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2025-2030 (USD MILLION)
TABLE 255. CANADA IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2024 (USD MILLION)
TABLE 256. CANADA IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2025-2030 (USD MILLION)
TABLE 257. CANADA IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 258. CANADA IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 259. CANADA IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2024 (USD MILLION)
TABLE 260. CANADA IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2025-2030 (USD MILLION)
TABLE 261. CANADA IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2024 (USD MILLION)
TABLE 262. CANADA IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2025-2030 (USD MILLION)
TABLE 263. CANADA IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2024 (USD MILLION)
TABLE 264. CANADA IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2025-2030 (USD MILLION)
TABLE 265. CANADA IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 266. CANADA IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 267. CANADA IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2024 (USD MILLION)
TABLE 268. CANADA IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2025-2030 (USD MILLION)
TABLE 269. CANADA IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2024 (USD MILLION)
TABLE 270. CANADA IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2025-2030 (USD MILLION)
TABLE 271. CANADA IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2024 (USD MILLION)
TABLE 272. CANADA IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2025-2030 (USD MILLION)
TABLE 273. CANADA IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 274. CANADA IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 275. CANADA IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 276. CANADA IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 277. CANADA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. CANADA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. CANADA IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. CANADA IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. CANADA IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. CANADA IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. CANADA IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 284. CANADA IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 285. CANADA IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
TABLE 286. CANADA IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
TABLE 287. CANADA IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2024 (USD MILLION)
TABLE 288. CANADA IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2025-2030 (USD MILLION)
TABLE 289. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 292. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 293. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2024 (USD MILLION)
TABLE 294. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2025-2030 (USD MILLION)
TABLE 295. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2024 (USD MILLION)
TABLE 296. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2025-2030 (USD MILLION)
TABLE 297. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 298. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 299. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2024 (USD MILLION)
TABLE 300. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2025-2030 (USD MILLION)
TABLE 301. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2024 (USD MILLION)
TABLE 302. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2025-2030 (USD MILLION)
TABLE 303. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2024 (USD MILLION)
TABLE 304. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2025-2030 (USD MILLION)
TABLE 305. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 306. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 307. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2024 (USD MILLION)
TABLE 308. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2025-2030 (USD MILLION)
TABLE 309. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2024 (USD MILLION)
TABLE 310. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2025-2030 (USD MILLION)
TABLE 311. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2024 (USD MILLION)
TABLE 312. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2025-2030 (USD MILLION)
TABLE 313. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 314. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 315. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 316. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 317. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 322. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 323. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 324. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 325. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2018-2024 (USD MILLION)
TABLE 326. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY FORMAT, 2025-2030 (USD MILLION)
TABLE 327. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2018-2024 (USD MILLION)
TABLE 328. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY LABEL TYPE, 2025-2030 (USD MILLION)
TABLE 329. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 330. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 331. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 332. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 333. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2018-2024 (USD MILLION)
TABLE 334. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY MONOCLONAL, 2025-2030 (USD MILLION)
TABLE 335. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2018-2024 (USD MILLION)
TABLE 336. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY POLYCLONAL, 2025-2030 (USD MILLION)
TABLE 337. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 338. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 339. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2018-2024 (USD MILLION)
TABLE 340. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY ANTIGENS, 2025-2030 (USD MILLION)
TABLE 341. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2018-2024 (USD MILLION)
TABLE 342. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY PEPTIDE ANTIGENS, 2025-2030 (USD MILLION)
TABLE 343. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2018-2024 (USD MILLION)
TABLE 344. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY PROTEIN ANTIGENS, 2025-2030 (USD MILLION)
TABLE 345. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 346. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 347. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2018-2024 (USD MILLION)
TABLE 348. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY ELISA KITS, 2025-2030 (USD MILLION)
TABLE 349. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2018-2024 (USD MILLION)
TABLE 350. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY IHC KITS, 2025-2030 (USD MILLION)
TABLE 351. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2018-2024 (USD MILLION)
TABLE 352. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY WESTERN BLOT KITS, 2025-2030 (USD MILLION)
TABLE 353. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 354. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 355. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 356. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY SECONDARY ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 357. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Immunochemicals market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Becton, Dickinson and Company
  • Abcam plc
  • Bio-Techne Corporation
  • Promega Corporation

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.35 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.76 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Fecal Immunochemical Test Kits Market by Product Type (Automated Kits, Manual Kits), Sample Format (Cartridges, Cassettes), Distribution Channel, Technology, End User - Global Forecast 2025-2030 - Product Image

Fecal Immunochemical Test Kits Market by Product Type (Automated Kits, Manual Kits), Sample Format (Cartridges, Cassettes), Distribution Channel, Technology, End User - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Immunochemicals - Global Strategic Business Report - Product Image

Immunochemicals - Global Strategic Business Report

  • Report
  • 312 Pages
  • Global
From
Polyclonal Antibodies - Global Strategic Business Report - Product Image

Polyclonal Antibodies - Global Strategic Business Report

  • Report
  • 462 Pages
  • Global
From
Polyclonal Antibodies Market Report 2025 - Product Image

Polyclonal Antibodies Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Report 2025 - Product Image

Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Immunochemicals Market

The Immunochemicals market is a subset of the Immune Disorders Drugs market, which focuses on the development of treatments for diseases related to the immune system. Immunochemicals are a type of drug that modulate the immune system, either by stimulating or suppressing it. These drugs are used to treat a variety of conditions, including autoimmune diseases, allergies, and cancer. Immunochemicals can be administered orally, intravenously, or topically, depending on the condition being treated. Immunochemicals are often used in combination with other treatments, such as chemotherapy or radiation therapy, to maximize the effectiveness of the treatment. Additionally, immunochemicals can be used to reduce the side effects of other treatments, such as reducing inflammation or suppressing the immune system. Some companies in the Immunochemicals market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.